Price to Book Value Chart

View Price to Book Value for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
August 24, 2026 15.15
August 21, 2026 15.68
August 20, 2026 15.41
August 19, 2026 14.71
August 18, 2026 13.05
August 17, 2026 13.27
August 14, 2026 13.19
August 13, 2026 13.03
August 12, 2026 13.05
August 11, 2026 13.41
August 10, 2026 13.15
August 07, 2026 13.61
August 06, 2026 13.05
August 05, 2026 13.17
August 04, 2026 12.77
August 03, 2026 9.268
July 31, 2026 8.971
July 30, 2026 9.249
July 29, 2026 8.615
July 28, 2026 8.813
July 27, 2026 8.714
July 24, 2026 9.268
July 23, 2026 9.803
July 22, 2026 9.783
July 21, 2026 9.625
Date Value
July 20, 2026 9.268
July 17, 2026 8.694
July 16, 2026 8.417
July 15, 2026 8.516
July 14, 2026 8.100
July 13, 2026 8.199
July 10, 2026 8.813
July 09, 2026 9.150
July 08, 2026 8.635
July 07, 2026 9.506
July 06, 2026 8.714
July 02, 2026 8.991
July 01, 2026 9.328
June 30, 2026 9.209
June 29, 2026 7.928
June 26, 2026 7.644
June 25, 2026 7.744
June 24, 2026 7.544
June 23, 2026 7.269
June 22, 2026 7.377
June 18, 2026 7.578
June 17, 2026 7.094
June 16, 2026 7.594
June 15, 2026 7.628
June 12, 2026 7.794

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Myriad Genetics, Inc. 0.9658
BioRestorative Therapies, Inc. 1.853
CareDx, Inc. 5.827
Natera, Inc. 26.22
Sera Prognostics, Inc. 1.448

Price to Book Value Related Metrics

PS Ratio 2.575
Price 7.75
Earnings Yield -10.40%
Market Cap 187.50M